Literature DB >> 1913471

Merkel cell carcinoma. Improved locoregional control with postoperative radiation therapy.

R B Wilder1, P M Harari, A R Graham, D S Shimm, J R Cassady.   

Abstract

Between April 1981 and May 1990, 11 patients with Merkel cell carcinoma were treated with radiation therapy in Tucson, Arizona. The length of follow-up time from the time of irradiation ranged from 6 to 64 months. Locoregional control was maintained in seven of eight patients treated with surgery and postoperative radiation therapy for primary or recurrent cancer. The other three patients had bulky metastatic disease at the time of referral. Palliation was achieved in all three patients with radiation therapy. Hyperthermia also appeared to be beneficial in the one patient in which it was used, and chemotherapy achieved responses in two of four patients. These results, combined with a review of the literature, suggest that the administration of radiation therapy postoperatively to both the surgical bed and the draining lymph nodes improves locoregional control and may result in long-term disease-free survival when administered after the initial surgical resection.

Entities:  

Mesh:

Year:  1991        PMID: 1913471     DOI: 10.1002/1097-0142(19910901)68:5<1004::aid-cncr2820680516>3.0.co;2-8

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  4 in total

Review 1.  Merkel cell carcinoma.

Authors:  Emma Ramahi; Jehee Choi; Clifton D Fuller; Tony Y Eng
Journal:  Am J Clin Oncol       Date:  2013-06       Impact factor: 2.339

Review 2.  [Primary radiotherapy of recurrent Merkel cell carcinoma of the eyelid. Case report and review of the literature].

Authors:  S Höcht; T Wiegel
Journal:  Strahlenther Onkol       Date:  1998-06       Impact factor: 3.621

3.  A practical update of surgical management of merkel cell carcinoma of the skin.

Authors:  Patricia Tai
Journal:  ISRN Surg       Date:  2013-01-30

Review 4.  Merkel cell carcinoma.

Authors:  Michael S Lehrer; Diane Hershock; Michael E Ming
Journal:  Curr Treat Options Oncol       Date:  2004-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.